Women’s health and Fifty Shades: Increased risks for young adult readers?

PUBLIC RELEASE DATE:

21-Aug-2014

Contact: Kathryn Ryan kryan@liebertpub.com 914-740-2100 Mary Ann Liebert, Inc./Genetic Engineering News

New Rochelle, NY, August 21, 2014Popular fiction that normalizes and glamorizes violence against women, such as the blockbuster Fifty Shades series, may be associated with a greater risk of potentially harmful health behaviors and risks. The results of a provocative new study are presented in the article "Fiction or Not? Fifty Shades Is Associated with Health Risks in Adolescent and Young Adult Females," published in Journal of Women's Health, a peer-reviewed publication from Mary Ann Liebert, Inc., publishers. The article is available free on the Journal of Women's Health website.

Amy Bonomi and coauthors from Michigan State University (East Lansing, MI), Group Health Research Institute (Seattle, WA), and Ohio State University (Columbus, OH) compared young women ages 18-24, readers versus non-readers of at least the first novel in the Fifty Shades series based on self-reports of intimate partner violence victimization (including shouting, swearing, delivering unwanted calls or text messages, and other forms of verbal/emotional abuse, stalking, as well as physical and sexual abuse), binge drinking, disordered eating (use of diet aids and fasting for more than 24 hours), and sexual practices such as number of intercourse partners during their lifetime. The findings point to a substantially greater risk for certain adverse health behaviors among the group that read Fifty Shades, which hyper-sexualizes women and may reaffirm and create the context for those behaviors.

"Clearly, we need a better understanding of the association between reading popular fiction that depicts violence towards women and engaging in risky health behaviors, particularly among adolescent and young adult women," says Susan G. Kornstein, MD, Editor-in-Chief of Journal of Women's Health, Executive Director of the Virginia Commonwealth University Institute for Women's Health, Richmond, VA, and President of the Academy of Women's Health.

###

About the Journal

Journal of Women's Health, published monthly, is a core multidisciplinary journal dedicated to the diseases and conditions that hold greater risk for or are more prevalent among women, as well as diseases that present differently in women. The Journal covers the latest advances and clinical applications of new diagnostic procedures and therapeutic protocols for the prevention and management of women's healthcare issues. Complete tables of content and a sample issue may be viewed on the Journal of Women's Health website. Journal of Women's Health is the official journal of the Academy of Women's Health and the Society for Women's Health Research.

About the Society

Continue reading here:
Women's health and Fifty Shades: Increased risks for young adult readers?

Conclusive evidence on role of circulating mesenchymal stem cells in organ injury

PUBLIC RELEASE DATE:

21-Aug-2014

Contact: Kathryn Ryan kryan@liebertpub.com 914-740-2100 Mary Ann Liebert, Inc./Genetic Engineering News

New Rochelle, NY, August 21, 2014--Mesenchymal stem cells (MSCs) are present in virtually every type of human tissue and may help in organ regeneration after injury. But the theory that MSCs are released from the bone marrow into the blood stream following organ damage, and migrate to the site of injury, has long been debated. M.J. Hoogduijn and colleagues provide conclusive evidence to resolve the controversy over the mobilization and migration of MSCs in humans in a new study published in Stem Cells and Development, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers. The article is available on the Stem Cells and Development website.

In "No Evidence for Circulating Mesenchymal Stem Cells in Patients with Organ Injury," Hoogduijn and coauthors from Erasmus University Medical Center (Rotterdam, The Netherlands), describe the results of studies to detect MSCs in the blood of healthy individuals, of patients with end-stage renal disease, of patients with end-stage liver disease, and of heart transplant patients with organ rejection. Whereas they did not find MSCs in the circulation of these individuals, they did report the presence of MSCs in the blood of a patient suffering from severe trauma with multiple fractures. In the trauma patient, the circulating MSCs likely derived from disruption of the bone marrow caused by the fractures.

"We can add the simple but elegant work of Martin Hoogduijn to the pantheon of studies in stem cell research that skewer a long treasured tenet of faith and consign it to mythology," says Editor-in-Chief Graham C. Parker, PhD, The Carman and Ann Adams Department of Pediatrics, Wayne State University School of Medicine, Detroit, MI.

###

About the Journal

Stem Cells and Development is an authoritative peer-reviewed journal published 24 times per year in print and online. The Journal is dedicated to communication and objective analysis of developments in the biology, characteristics, and therapeutic utility of stem cells, especially those of the hematopoietic system. A complete table of contents and free sample issue may be viewed on the Stem Cells and Development website.

About the Publisher

Read the original:
Conclusive evidence on role of circulating mesenchymal stem cells in organ injury

Superhero Science: Marvel Comics Gets Inside the Heads of the Avengers

The neuroscience behind the Hulk, Captain America and Iron Man, explained in a Times Square exhibit. Excelsior!

AVENGERS ASSEMBLE! To simulate Iron Mans HUD at the Avengers S.T.A.T.I.O.N. Exhibition, Neuroverse developed a novel electroencephalographic (EEG) braincomputer interface that activates when visitors press their foreheads against the EEG sensor. The sensor detects brain waves and converts these signals into commands that the on-screen HUD simulation follows. Courtesy of Neuroverse, Inc.

The job of creating superheroes has become more complicated in the 50-plus years since Marvel Comics first assembled the Avengers to fight evil. Audiences today still crave fantastical adventures but at the same time demand a greater degree of plausibility. In response Marvel gathered a real-life team of scientists to ensure that its Avengers S.T.A.T.I.O.N. Exhibition currently on display in New York Citys Times Square includes elements of realism as it explores Marvels superhero mythology. Beyond simply being a colossal advertisement for its brand, the exhibit enables Marvel to delve into the neuroscience behind Dr. Bruce Banners metamorphosis into his green alter ego as well as Capt. Steve Rogerss transformation into a supersoldier. Another key exhibit mimics the heads-up display that billionaire industrialist Tony Stark uses in his Iron Man suit. The general public has become more educated about science, so Marvel has had to work harder to come up with explanations that allow the audience suspend disbelief, says neurobiologist Ricardo Gil-da-Costa, a science advisor for Marvels Agents of S.H.I.E.L.D. TV program. Gil-da-Costa, whose company Neuroverse consulted on aspects of the exhibition related to neuroscience and helped build Iron Mans heads-up display demonstration, began speaking with the Avengers S.T.A.T.I.O.N. creators two years ago in an effort to craft the right mix of entertainment backed by real science. The Hulk The Hulks legend has grown in the half century since Marvel introduced his character, best known for smashing, grunting and shredding Bruce Banners wardrobe. Much less is known about the neurological transition that the physicists brain undergoes each time he transforms from an articulate 58-kilogram man into the 470-kilogram green brute. Exhibit makers determined that the Hulk in particular provided a unique opportunity to help young visitors understand how the human brain works. The first step was to evaluate the green superheros powers and reverse engineer some of them back to their neurological roots, Gil-da-Costa says. The Hulk demo within the sprawling, 930-square-meter S.T.A.T.I.O.N. exhibit begins with an actual MRI scan of a human brain that represents Banners gray matter. Simulation software portrays the anatomical changes that the doctors brain undergoes as he becomes the Hulk.

The angrier Hulk gets Supervillains know, or at least they should by now, to take cover when the Hulk starts his rampagehis strength is directly proportional to his level of rage. Banners conversion from a mild-mannered scientist to his superhero persona results in a 20 percent growth in his amygdala, coupled with a 30 percent reduction of the prefrontal cortex, which decreases his ability to control rational reflection and decision-making. This change is responsible for the Hulks highly emotional behavior, during which he typically reacts with impetuous emotions rather than lucid thought. The amygdala, a small, almond-shaped structure located deep in the lower part of the temporal lobe, is associated with the processing of emotions and contributes to memory formation. The prefrontal cortex, meanwhile, receives information from other brain areas to perform cognitive processes like problem solving, prediction of outcomes, decision-making and behavioral planning. Hulk is going now! Don't try to follow! The Hulk is capable of incredibly long leaps, as far as 1,600 kilometers by some estimates. To cover such distances and land in the right spot, the Hulk needs rapid and increased visual processing while moving at high speeds, Gil-da-Costa says. To do this the visual cortex in Banners brain grows about 15 percent in size when he becomes the Hulk, enabling him to better perceive, discriminate and structure what he sees. Likewise, a 50 percent growth in Banners cerebellumfundamental for motor control, equilibrium, coordination and timinghelps give the Hulk the balance, spatial processing and precision he needs to land on his big, green feet. Hulk smash! (Well, smashes) Hulk has also been known to lay waste to the English language. That probably has to do with the 25 percent reduction in Banners planum temporale, which changes his brains capacity for language and causes the Hulk to lose the ability for fluent speech, according to Gil-da-Costa. The planum temporale is highly asymmetriclarger in the left hemispherea characteristic thought to be part of the human evolution to specialize brain areas for language. A computer simulation at the exhibition shows that Banners brain loses this asymmetry when he gets Hulked up.

Captain America Unlike Hulks repeated transformations Steve Rogerss conversion into Captain America occurred only once and produced mostly positive benefits, including strength and agility, without affecting his capacity for reasoning or language. The supersoldier serum that Professor Abraham Erskine injected into Rogers actually led to increased neural connectivity between brain areas that he frequently activates. In his case, the amygdala,orbitofrontal cortex, prefrontal cortexand visual cortex as well as the motor, pre-motor andsomatosensory regions. Working together this network of brain areas processes aspects of a persons understanding of what others are feeling, in other words aspects of empathy and concern for others, Gil-da-Costa says. Gil-da-Costa and his team posit that Captain Americas superhuman handeye coordination, reflexes, motor speed and muscle response could be side effects of the increased connections between visual cortex and premotor and motor areas. A phenomenon called synesthesiaa neurological condition of increased connectivity between brain areas in which stimulation of one sense automatically activates a second sensewas also part of the inspiration for Captain Americas brain. People with this condition hear colors, for instance. Captain America doesn't have synesthesia per se, but the same underlying phenomena of increased connectivity occur, Gil-da-Costa says. So, it was an inspiration for the designing his brain and structuring it in real science. Iron Man Tony Starks enhanced abilities come from neural prosthetics in his metal suit rather than actual changes to his brain. Stark activates different areas of his suit using, amongst other things, a braincomputer interface that converts his brain signals into instructions that his suits computer uses to control its flight and fire weapons as well as work the heads-up display (HUD), which gives Iron Man precise information about his surroundings. To simulate Iron Mans HUD at the Avengers S.T.A.T.I.O.N. Exhibition, Neuroverse developed a novel electroencephalographic (EEG) braincomputer interface powered by the low-voltage electrical activity that enables brain cells to communicate. This three-electrode EEG is connected to a small display screen. The interface activates when visitors press their foreheads against the EEG sensor, which detects brain waves and converts these signals into commands that the on-screen HUD simulation follows. This technology, integrated with an additional
eye-tracking system from The Eye Tribe, allows visitors to navigate the display to watch video clips, play games and see a graph depicting their neural activity in real-time. The development an accurate EEG-based braincomputer interface that would work for the exhibits large and constantly churning audience proved particularly challenging. Exhibit creators developed specific hardware related to sensing the brain and algorithms to interpret an individuals brain signals. This software requires some degree of recalibration when a new visitor engages the exhibit because each persons brain and thought patternseven in response to the same stimuliare unique. Neuroverses sensor begins to take readings when a forehead is pressed against it. This also serves to keep the persons head fairly still so that the system can more easily read brain waves. Marvels Avengers S.T.A.T.I.O.N. Exhibition is on display through January 4, 2015. Neuroverse is working on a small, multi-use wireless braincomputer interface for use in everyday life. That system is expected to be a low-cost mobile device for monitoring various types of neural activity and sharing that information via a smartphone app.

Here is the original post:
Superhero Science: Marvel Comics Gets Inside the Heads of the Avengers

Life on Mars? Implications of a newly discovered mineral-rich structure

PUBLIC RELEASE DATE:

19-Aug-2014

Contact: Kathryn Ryan kryan@liebertpub.com 914-740-2100 Mary Ann Liebert, Inc./Genetic Engineering News

New Rochelle, August 19, 2014A new ovoid structure discovered in the Nakhla Martian meteorite is made of nanocrystalline iron-rich clay, contains a variety of minerals, and shows evidence of undergoing a past shock event from impact, with resulting melting of the permafrost and mixing of surface and subsurface fluids. Based on the results of a broad range of analytical studies to determine the origin of this new structure, scientists present the competing hypotheses for how this ovoid formed, point to the most likely conclusion, and discuss how these findings impact the field of astrobiology in a fascinating article published in Astrobiology, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers. The article is available Open Access on the Astrobiology website.

In the article, "A Conspicuous Clay Ovoid in Nakhla: Evidence for Subsurface Hydrothermal Alteration on Mars with Implications for Astrobiology," Elias Chatzitheodoridis, National Technical University of Athens, Greece, and Sarah Haigh and Ian Lyon, the University of Manchester, UK, describe the use of tools including electron microscopy, x-ray, and spectroscopy to analyze the ovoid structure. While the authors do not believe the formation of this structure involved biological materials, that is a possible hypothesis, and they note that evidence exists supporting the presence of niche environments in the Martian subsurface that could support life.

"This study illustrates the importance of correlating different types of datasets when attempting to discern whether something in rock is a biosignature indicative of life," says Sherry L. Cady, PhD, Editor-in-Chief of Astrobiology and Chief Scientist at the Pacific Northwest National Laboratory. "Though the authors couldn't prove definitively that the object of focus was evidence of life, their research strategy revealed a significant amount of information about the potential for life to inhabit the subsurface of Mars."

###

About the Journal

Astrobiology, led by Editor-in-Chief Sherry L. Cady, Chief Scientist at the Pacific Northwest National Laboratory, and a prominent international editorial board comprised of esteemed scientists in the field, is the authoritative peer-reviewed journal for the most up-to-date information and perspectives on exciting new research findings and discoveries emanating from interplanetary exploration and terrestrial field and laboratory research programs. The Journal is published monthly online with Open Access options and in print. Complete tables of content and a sample issue may be viewed on the Astrobiology website.

About the Publisher

See more here:
Life on Mars? Implications of a newly discovered mineral-rich structure

Sequencing the genome of salamanders

4 hours ago by Keith Hautala

University of Kentucky biologist Randal Voss is sequencing the genome of salamanders. Though we share many of the same genes, the salamander genome is massive compared to our own, about 10 times as large.

Voss's research focuses on axolotls, salamanders with amazing regenerative ability.

"It's hard to find a body part they can't regenerate: the limbs, the tail, the spinal cord, the eye, and in some species, the lens, half of their brain has been shown to regenerate," Voss said."I'm very fortunate to have a colleague in the department, Jeramiah Smith, who's an expert at the ability to put small pieces of DNA together to kind of recreate the puzzle, which is the genome. We have funding from the National Institute of Health and the Department of Defense to sequence the axolotl genome and provide this blueprint for the first time."

With a partner at the University of Dayton, Voss is looking at the loss of regenerative ability in the eye as a salamander ages.

"Early on in life, axolotls can regenerate their lens. But at some point in time, around 28 days after they hatch, that plasticity goes away and they can't regenerate the lens," Voss said. "So, I've been working with that group trying to identify the genes that might explain that."

Voss is also starting a new collaboration with an orthopedic surgeon at UK to study knee joint regeneration.

This video is not supported by your browser at this time.

"Over the course of say 10 to 15 days, the salamander will successfully regenerate a complete joint. That blows the orthopedic surgeon's mind because that would be the Holy Grail in their field to understand how to orchestrate joint regeneration in a human."

Explore further: Researchers cohere research cluster focusing on genetic mechanisms underscoring regeneration

See the rest here:
Sequencing the genome of salamanders

Insights from the Behavioral Science Guy: The fastest way to change your behavior is to change your environment

Something as simple as the size of a plate and spoon can influence how much a person eats, according to Joseph Grenny.

Shutterstock

Enlarge photo

Next time you procrastinate, overeat, lose your temper, text while driving, chicken out on a tough conversation pick your sin try something new.

Dont blame yourself. Blame your environment.

The central message of the past five decades of social science research is this: We have far less control over our behavior than we think.

Now, lest you think Im about to justify criminals and go soft on personal responsibility, Im not. In fact, Im going to share with you the key to truly taking control of your life. Here it is crochet it onto a sampler, make it your laptop wallpaper, tattoo it on your forehead:

The best way to control your behavior is to take control of the things that control you.

It turns out that those who most appreciate how little control they have over their own behavior are the best equipped to change it.

Today, Ill share one illustration of this empowering idea. In future columns, Ill add others. Keep reading and youll have a complete view of all of the sources of influence that shape our choices and, therefore, a powerful way of taking control of your life.

See more here:
Insights from the Behavioral Science Guy: The fastest way to change your behavior is to change your environment

MetroMD Offers Revolutionary Anti-aging Hormone Therapy in Hollywood Area

Los Angeles, CA (PRWEB) August 20, 2014

If old age is a disease then this L.A. based clinic has found a cure for it. With extensive research on HGH and stem cells technology, the L.A. based HGH Therapy provider named MetroMD claims to have perfected the art of rubbing off decades from your face and body and give you a brand new younger look with their revolutionary anti-aging hormone therapy and regenerative medicine.

When asked the secrets of the 21st century fountain of youth, the MD of MetroMD, Dr Alex Martin said this with aplomb Old age is like just another disease. We all want to live longer and look young and good-looking. Our HGH therapy results and regenerative medicine therapy have made clients, both men and women, look much younger and feel that way too. The benefit of HGH therapy dosage is that it helps both the pediatric group with growth disorders as well as the senior group with drastic aging symptoms and conditions like erectile dysfunction in men. Children with below normal growth get a normal growth and our regenerative medicine therapy removes the aging symptoms from aging men and women and makes them look decades younger and fit. No wonder our Botox Clinic Hollywood and Botox Clinic Los Angeles are drawing a huge crowd with a considerable celebrity clientele as well.

HGH or Human Growth Hormone is a natural occurring hormone in humans which regulates our growth, size and fitness. HGH Therapy provider clinics like MetroMD help their clients by giving them customized HGH therapy dosage on the basis of hormonal deficiencies. Testosterone HGH helps male patients having erectile deficiencies to gain back a very active sexual lifestyle. Botox therapy comes handy for those aging men and women who are showing signs of aging and who want to reverse their aging process. Because of all these beneficial features, MetroMDs HGH Hollywod story is a box-office hit.

Dr. Alex Martin, the MD of MetroMD made no bones about their HGH Therapy cost. He said Through our Botox Clinic Hollywood and Botox Clinic Los Angeles we cater to a very unique clientele for whom the cost factor is not much of a bother. Our HGH Therapy results deliver joy and satisfaction which no Earth money can buy. Still we keep our prices as reasonable as possible. He added with a chuckle The last time we checked only God could do what our HGH Therapy results are doing

Visit link:
MetroMD Offers Revolutionary Anti-aging Hormone Therapy in Hollywood Area

Training the next generation of cancer nanomedicine scientists

PUBLIC RELEASE DATE:

18-Aug-2014

Contact: Casey Bayer c.bayer@neu.edu 617-373-2592 Northeastern University

Northeastern University has received a five-year, $1.15 million grant from the National Institutes of Health's National Cancer Institute to train the next generation of cancer nanomedicine scientists and clinicians through a unique experiential learning program.

The centerpiece of the new program, which is called "CaNCURE: Cancer Nanomedicine Co-ops for Undergraduate Research Experiences," is a unique partnership between Northeastern and the Initiative to Eliminate Cancer Disparities at the Dana-Farber/Harvard Cancer Center. The DF/HCC is the world's largest comprehensive cancer center, bringing together the research efforts of its seven member institutions, comprising Beth Israel Deaconess Medical Center, Boston Children's Hospital, Brigham and Women's Hospital, Massachusetts General Hospital, Dana-Farber Cancer Institute, Harvard Medical School, and the Harvard School of Public Health. For more than a decade, the IECDamong the nation's first integrated, inter-institutional programs focused on eliminating cancer disparitieshas offered programming to address the complexities of cancer disparities, including training students, enhancing research, and facilitating access to underserved populations.

"Nanotechnology is leading to breakthroughs in diagnosis and therapy of many diseases, particularly cancer, leading to the new discipline of cancer nanomedicine," said principal investigator Srinivas Sridhar, Northeastern's Arts and Science Distinguished Professor of Physics, Bioengineering, and Chemical Engineering, and the director of the university's IGERT Nanomedicine Science and Technology program. "Advances in the field are beginning to have revolutionary impact on healthcare."

Over the next five years, a total of 75 undergraduate students will receive training to study and conduct cancer nanomedicine research in the laboratories of 35 leading scientists at Northeastern and DF/HCC. These six-month co-op experiences, facilitated through Northeastern's co-op office, will provide students in majors ranging from biomedical physics to chemical engineering with hands-on research experience and one-on-one mentoring from the leading researchers in cancer nanomedicine at these partner institutions.

"These mentors represent some of the world's best scientists in cancer nanomedicine research," Sridhar explained, noting that the undergraduate researchers will also have the opportunity to collaborate with their postdocs and graduate students. "We are tapping into an unprecedented resource of talent and expertise for teaching and the students' learning environment is going to be absolutely outstanding."

Sridhar, who expects to enroll the program's initial cohort of students this fall, has placed an emphasis on attracting young scientists from underrepresented minority groups. "Our goals are well aligned with that of NCI, which wants to ensure that segments of the population that are underrepresented in the scientific and healthcare professions have access to opportunities in research and professional development," he said.

All enrollees will participate in specialized workshops, conferences, and bi-monthly seminars featuring cancer nanomedicine experts. At the conclusion of the yearlong program, each student will give a presentation of his or her work.

See the article here:
Training the next generation of cancer nanomedicine scientists

Pigs’ hearts transplanted into baboon hosts remain viable more than a year

PUBLIC RELEASE DATE:

18-Aug-2014

Contact: Nicole Baritot press@aats.org 978-299-4520 American Association for Thoracic Surgery

Beverly, MA, August 18, 2014 Investigators from the National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health (NIH) have successfully transplanted hearts from genetically engineered piglets into baboons' abdomens and had the hearts survive for more than one year, twice as long as previously reported. This was achieved by using genetically engineered porcine donors and a more focused immunosuppression regimen in the baboon recipients, according to a study published in The Journal of Thoracic and Cardiovascular Surgery, an official publication of the American Association for Thoracic Surgery.

Cardiac transplantation is the treatment of choice for end stage heart failure. According to the NHLBI, approximately 3,000 people in the US are on the waiting list for a heart transplant, while only 2,000 donor hearts become available each year. For cardiac patients currently waiting for organs, mechanical assist devices are the only options available. These devices, however, are imperfect and experience issues with power supplies, infection, and problems with blood clots and bleeding.

Transplantation using an animal organ, or xenotransplantation, has been proposed as a valid option to save human lives. "Until we learn to grow organs via tissue engineering, which is unlikely in the near future, xenotransplantation seems to be a valid approach to supplement human organ availability. Despite many setbacks over the years, recent genetic and immunologic advancements have helped revitalized progress in the xenotransplantation field," comments lead investigator Muhammad M. Mohiuddin, MD, of the Cardiothoracic Surgery Research Program at the NHLBI.

Dr. Mohiuddin's group and other investigators have developed techniques on two fronts to overcome some of the roadblocks that previously hindered successful xenotransplantation. The first advance was the ability to produce genetically engineered pigs as a source of donor organs by NHLBI's collaborator, Revivicor, Inc. The pigs had the genes that cause adverse immunologic reactions in humans "knocked out" and human genes that make the organ more compatible with human physiology were inserted. The second advance was the use of target-specific immunosuppression, which limits rejection of the transplanted organ rather than the usual generalized immunosuppression, which is more toxic.

Pigs were chosen because their anatomy is compatible with that of humans and they have a rapid breeding cycle, among other reasons. They are also widely available as a source of organs.

In this study, researchers compared the survival of hearts from genetically engineered piglets that were organized into different experimental groups based on the genetic modifications introduced. The gene that synthesizes the enzyme alpha 1-3 galactosidase transferase was "knocked out" in all piglets, thus eliminating one immunologic rejection target. The pig hearts also expressed one or two human transgenes to prevent blood from clotting. The transplanted hearts were attached to the circulatory systems of the host baboons, but placed in the baboons' abdomens. The baboons' own hearts, which were left in place, maintained circulatory function, and allowed the baboons to live despite the risk of organ rejection.

The researchers found that in one group (with a human gene), the average transplant survival was more than 200 days, dramatically surpassing the survival times of the other three groups (average survival 70 days, 21 days, and 80 days, respectively). Two of the five grafts in the long-surviving group stopped contracting on postoperative days 146 and 150, but the other three grafts were still contracting at more than 200 to 500 days at the time of the study's submission for publication.

More here:
Pigs' hearts transplanted into baboon hosts remain viable more than a year

Pygmy phenotype developed many times, adaptive to rainforest

19 hours ago A Batwa young man in Bwindi Impenetrable Forest National Park, Uganda. Credit: George Perry, Penn State

The small body size associated with the pygmy phenotype is probably a selective adaptation for rainforest hunter-gatherers, according to an international team of researchers, but all African pygmy phenotypes do not have the same genetic underpinning, suggesting a more recent adaptation than previously thought.

"I'm interested in how rainforest hunter-gatherers have adapted to their very challenging environments," said George H. Perry, assistant professor of anthropology and biology, Penn State. "Tropical rainforests are difficult for humans to live in. It is extremely hot and humid with limited food, especially when fruit is not in season."

A phenotype is the outward expression of genetic makeup and while two individuals with the same phenotype may look alike, their genes may differ substantially. The pygmy phenotype exists in many parts of Africa, Southeast Asia, the Philippines and potentially in South America. The phenotype is usually associated with rainforest hunter-gathers, groups of people who do not farm, but obtain resources by hunting large and small animals and gathering fruit, nuts, insects and other available resources.

Perry and colleagues looked at the genetics of the Batwa rainforest hunter-gatherers of Uganda and compared them to their farming neighbors, the Bakiga, with whom they traditionally traded forest products for grain, and sometimes intermarry. The researchers also looked at the Baka rainforest hunter-gatherers and their farming neighbors the Nzebi/Nzime in central Africa. They report their results online today (Aug. 18) in the Proceedings of the National Academies of Science.

The average height for Batwa men is five foot and for women it is four foot eight inches. Their short stature is not caused by a single genetic mutation as occurs in many forms of dwarfism, but is the result of a variety of genetic changes throughout the genome that influence height.

The researchers investigated 16 different genetic locations that were associated with short stature when they looked at individuals who were an admixture of Batwa and Bakiga. Several of these regions contained genes known to be involved with growth in humans. They then studied these regions to look for indications that the changes were ones that persisted because they were adaptive.

Genetic mutations occur in populations all the time. If they have a negative impact on the individual, they tend to disappear from the population quickly. If they have no noticeable impact for the good or bad, they might disappear as well, although more slowly. Mutations which have positive influence on individuals, making them more fit for their environment, tend to spread through the population.

Short stature may be adaptive for rainforest individuals for a variety of reasons, according to Perry. Small bodies require less food, which is adaptive for a food-limited location like the rainforest. Small bodies also generate less heat, which, in the heat and humidity of the rainforest, is adaptive. It is also easier for small, agile individuals to move through dense undergrowth and to climb trees.

The results of the genetic comparison indicated that there was a statistical difference between the two groups indicative of multi gene adaptation.

Continued here:
Pygmy phenotype developed many times, adaptive to rainforest

Sequencing at sea: Real-time DNA sequencing in a remote field location

3 hours ago San Diego State University graduate student Yan Wei Lim is exploring coral reefs in the southern Line Islands. Credit: Rob Edwards, SDSU computer scientist

Daylight was breaking over the central Pacific and coffee brewing aboard the MY Hanse Explorer. Between sips, about a dozen scientists strategized for the day ahead. Some would don wetsuits and slip below the surface to collect water samples around the southern Line Islands' numerous coral reefs. Others would tinker with the whirring gizmos and delicate machinery strewn throughout the 158-foot research vessel. All shared a single goal: Be the first research group to bring a DNA sequencer out into the field to do remote sequencing in real time. Against an ocean of odds, they succeeded.

This three-week, five-island expedition took place last year with a research crew including San Diego State University computer scientist Rob Edwards, biologist Forest Rohwer, postdoctoral scholar Andreas Haas and graduate student Yan Wei Lim. They were accompanied by several other researchers from the San Diego region and around the world. The researchers published an account of their trip and methods today in the journal PeerJ.

Line Island investigations

Biologists and computer scientists at SDSU have been traveling to the Line Islands for the last decade, collecting and analyzing the coral habitat to better understand what organisms live there, how they compete for resources, and what effects their presence has on the reef's ecosystem. It always bothered Edwards that they had to wait until they were back home, on the other side of the world, before they could look at their data and develop new hypotheses.

"If only we had had that data out in the field, we could have asked those questions there and then," Edwards said.

That inkling grew into an ambitious plan to somehow, some way bring out to sea a cumbersome and expensive piece of equipment designed to analyze a sample's DNA makeup and spit out detailed information about its genome.

The project initially had its doubters.

"People are a little bit hesitant to take a half-million-dollar piece of equipment into the middle of the Pacific if you're not sure it's going to be coming back," Edwards said.

This video is not supported by your browser at this time.

Read the original:
Sequencing at sea: Real-time DNA sequencing in a remote field location

Are children who play violent video games at greater risk for depression?

PUBLIC RELEASE DATE:

18-Aug-2014

Contact: Kathryn Ryan kryan@liebertpub.com 914-740-2100 Mary Ann Liebert, Inc./Genetic Engineering News

New Rochelle, NY, August 18, 2014While much attention has focused on the link between violent video game playing and aggression among youths, a new study finds significantly increased signs of depression among preteens with high daily exposure to violent video games. The details and implications of this important new study are described in Cyberpsychology, Behavior, and Social Networking, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers. The article is available free on the Cyberpsychology, Behavior, and Social Networking website.

Susan R. Tortolero, PhD and coauthors from The University of Texas Health Science Center at Houston School of Public Health, RAND Corporation (Santa Monica, CA), The University of Alabama at Birmingham, Centers for Disease Control and Prevention (Atlanta, GA), and Boston Children's Hospital and Harvard Medical School (Boston, MA) recorded significantly more depressive symptoms over the course of a year among fifth-graders from three U.S. cities who reported playing high-violence video games for 2 or more hours a day, compared to those who reported playing low-violence video games for less than 2 hours a day. This association was consistent across all racial/ethnic subgroups and among boys, according to the study results presented in the article "Daily Violent Video Game Playing and Depression in Preadolescent Youth."

"One of the strengths of this study is its large and ethnically diverse sample," says Editor-in-Chief Brenda K. Wiederhold, PhD, MBA, BCB, BCN, Interactive Media Institute, San Diego, California and Virtual Reality Medical Institute, Brussels, Belgium.

###

About the Journal

Cyberpsychology, Behavior, and Social Networking is an authoritative peer-reviewed journal published monthly online with Open Access options and in print that explores the psychological and social issues surrounding the Internet and interactive technologies plus cybertherapy and rehabilitation, plus cybertherapy and rehabilitation. Complete tables of contents and a sample issue may be viewed on the Cyberpsychology, Behavior, and Social Networking website.

About the Publisher

View post:
Are children who play violent video games at greater risk for depression?

More than just X and Y: A new genetic basis for sex determination

20 hours ago Cold Spring Harbor Laboratory researchers have found that miRNAs, short RNA molecules, are responsible for sexual differences in fruit flies. Shown here are testes from a male fruit fly where a hormone that controls a key miRNA has been inactivated. The abnormal testes fail to make sperm. They now produce sex determinants (shown in red) that are found in the ovaries of female flies. Credit: D. Fagegaltier/ Cold Spring Harbor Laboratory

Men and women differ in plenty of obvious ways, and scientists have long known that genetic differences buried deep within our DNA underlie these distinctions. In the past, most research has focused on understanding how the genes that encode proteins act as sex determinants. But Cold Spring Harbor Laboratory (CSHL) scientists have found that a subset of very small genes encoding short RNA molecules, called microRNAs (miRNAs), also play a key role in differentiating male and female tissues in the fruit fly.

A miRNA is a short segment of RNA that fine-tunes the activation of one or several protein-coding genes. miRNAs are able to silence the genes they target and, in doing so, orchestrate complex genetic programs that are the basis of development.

In work published in Genetics, a team of CSHL researchers and colleagues describe how miRNAs contribute to sexual differences in fruit flies. You've probably never noticed, but male and female flies differ visibly, just like other animals. For example, females are 25% larger than males with lighter pigmentation and more abdominal segments.

The team of researchers, including Delphine Fagegaltier, PhD, lead author on the study, and CSHL Professor and Howard Hughes Medical Institute Investigator Greg Hannon, identified distinct miRNA populations in male and female flies. "We found that the differences in miRNAs are important in shaping the structures that distinguish the two sexes," says Fagegaltier. "In fact, miRNAs regulate the very proteins that act as sex determinants during development."

The team found that miRNAs are essential for sex determination even after an animal has grown to adulthood. "They send signals that allow germ cells, i.e., eggs and sperm, to develop, ensuring fertility," Fagegaltier explains. "Removing one miRNA from mature, adult flies causes infertility." More than that, these flies begin to produce both male and female sex-determinants. "In a sense, once they have lost this miRNA, the flies become male and female at the same time," according to Fagegaltier. "It is amazing that the very smallest genes can have such a big effect on sexual identity."

Some miRNAs examined in the study, such as let-7, have been preserved by evolution because of their utility; humans and many other animals carry versions of them. "This is probably just the tip of the iceberg," says Fagegaltier. "There are likely many more miRNAs regulating sexual identity at the cellular and tissue level, but we still have a lot to learn about these differences in humans, and how they could contribute to developmental defects and disease."

Explore further: Scientists identify a gene that controls the timing of precisely ordered events during maturation

More information: "A Genome-Wide Survey of Sexually Dimorphic Expression of Drosophila miRNAs Identifies the Steroid Hormone-Induced miRNA let-7 as a Regulator of Sexual Identity" appeared online in Genetics on July 31, 2014.

Closely related organisms share most of their genes, but these similarities belie major differences in behavior, intelligence, and physical appearance. For example, we share nearly 99% of our genes with chimps, ...

Originally posted here:
More than just X and Y: A new genetic basis for sex determination

Forestry geneticists develop tree biomass crop to grow on marginal lands

1 hour ago Amy Brunner

Two Virginia Tech researchers have received a $1.4 million grant to investigate the genetic regulatory networks that will allow an important bioenergy crop to be bred so it will grow in less than ideal soils and climate.

Populus, a genus of fast-growing trees commonly known as cottonwoods and aspens, is being grown for bioenergy because it produces a significant amount of biomass in two years and will re-grow robustly when cut at just above ground level. Woody biomass can be converted to liquid fuels, such as ethanol.

"The goal is to develop the species so it will not become dormant in conditions that would stress other crops, such as high temperature, drought, or marginal soil nutrients," said Amy Brunner, associate professor of molecular genetics in the College of Natural Resources and Environment and an affiliate of the Fralin Life Science Institute. "It is important that bioenergy crops not require prime agricultural land."

"We don't want biomass production to compete with food production," she continued. "The aim is to minimize inputs, develop varieties that grow in different environments, and maximize biomass production."

Brunner and Jason Holliday, assistant professor of forest genetics and biotechnology in the college and a fellow Fralin Life Science Institute affiliate, received the grant from the U.S. Department of Agriculture National Institute of Food and Agriculture and the U.S. Department of Energy Office of Biological and Environmental Research. Their project is one of 10 grants awarded as part of the national strategy of sustainable biofuels production.

"The college made the decision to enter into the specialized and highly competitive research arena of molecular genetics, and Drs. Brunner and Holliday are making important contributions to the body of molecular genetics science of tree species," said Paul Winistorfer, dean of the college. "Developing alternative approaches to biofuel crops and their adaptation and success to a changing climate is a strategic and important contribution to our future energy needs."

Brunner and Holliday are experimenting with the FT2 gene, which regulates vegetative growth. "In addition to seasonal dormancy, which happens when days get shorter, a common response to stress by woody plants is to stop growing and wait for things to get better, which is important to natural populations' ability to survive adverse conditions," said Brunner.

"Jason and I are melding our expertise to understand growth and dormancy transitions," she continued. "We will identify specific control points that can be manipulated to maximize growth in different environments."

The FT2 gene integrates signals regarding environmental conditions, such as day length and drought, to control shoot growth or regrowth after harvest.

Excerpt from:
Forestry geneticists develop tree biomass crop to grow on marginal lands

Prioritizing suicide research can help lead to fewer suicide attempts, deaths

Suicide experts recommend research into early behavioral detection, interventions, use of mass media, and other areas, American Journal of Preventive Medicine reports

In a new supplement to the September issue of the American Journal of Preventive Medicine, experts address the state of the science on suicide prevention and provide useful recommendations for research to inform effective suicide prevention. Suicide has been a challenging and perplexing public health issue to study as it has many dimensions and underlying factors. Although much is known about the patterns and potential risk factors of suicide, the national suicide rate does not appear to have dropped over the last 50 years.

This groundbreaking supplement -- titled Expert Recommendations for U.S. Research Priorities in Suicide Prevention -- draws together topic experts across the spectrum of suicide prevention research, who have considered and proposed ways in which research improvements could more effectively reduce suicide. The 24 articles cover a broad range of scientific topics, from basic science regarding the neurobiological underpinnings of suicide to the dissemination and implementation of prevention strategies. They represent a subset of presentations made by suicide prevention experts to inform A Prioritized Research Agenda for Suicide Prevention: An Action Plan to Save Lives (Research Agenda), which was created by the National Action Alliance for Suicide Prevention's Research Prioritization Task Force (RPTF).

"The articles in this special supplement represent the collective thinking of suicide prevention experts from across the United States and several other countries about where research efforts might best be invested to address the vexing public health problem of suicide," say the supplement's guest editors Morton Silverman, MD, Jane E. Pirkis, PhD, Jane L. Pearson, PhD, and Joel T. Sherrill, PhD. "We are confident the articles will have a major influence on the suicide prevention research community."

The content of the supplement directly addresses research that will inform the following goals:

Proposed strategies include research into early detection of suicidal behavior, particularly among youth and adolescents, intervention, evidence-based follow-up care, and reducing stigma through the use of mass media.

Effective suicide prevention is a team effort, including both public and private partners. Contributors to the supplement stress that progress in the area of suicide prevention research will require interdisciplinary, collaborative science and that translational science and interdisciplinary research collaboration ("team science") will be critical for advancing science and ultimately identifying effective prevention strategies.

The supplement's guest editors conclude, "The papers in this supplement, like the Research Agenda itself, are intended as inspirational resources that highlight the challenges and rewards of engaging in suicide prevention research, and suggest future research directions that have the potential to advance the overall goal of reducing attempts and deaths."

The journal's supplement can be found online at: http://www.ajpmonline.org/issue/S0749-3797%2814%29X0015-2

Story Source:

See the rest here:
Prioritizing suicide research can help lead to fewer suicide attempts, deaths

Prioritizing suicide research can help lead to fewer suicide attempts and deaths

PUBLIC RELEASE DATE:

18-Aug-2014

Contact: Angela J. Beck ajpmmedia@elsevier.com 734-764-8775 Elsevier Health Sciences

Ann Arbor, MI, August 18, 2014 In a new supplement to the September issue of the American Journal of Preventive Medicine, experts address the state of the science on suicide prevention and provide useful recommendations for research to inform effective suicide prevention. Suicide has been a challenging and perplexing public health issue to study as it has many dimensions and underlying factors. Although much is known about the patterns and potential risk factors of suicide, the national suicide rate does not appear to have dropped over the last 50 years.

This groundbreaking supplementtitled Expert Recommendations for U.S. Research Priorities in Suicide Preventiondraws together topic experts across the spectrum of suicide prevention research, who have considered and proposed ways in which research improvements could more effectively reduce suicide. The 24 articles cover a broad range of scientific topics, from basic science regarding the neurobiological underpinnings of suicide to the dissemination and implementation of prevention strategies. They represent a subset of presentations made by suicide prevention experts to inform A Prioritized Research Agenda for Suicide Prevention: An Action Plan to Save Lives (Research Agenda), which was created by the National Action Alliance for Suicide Prevention's Research Prioritization Task Force (RPTF).

"The articles in this special supplement represent the collective thinking of suicide prevention experts from across the United States and several other countries about where research efforts might best be invested to address the vexing public health problem of suicide," say the supplement's guest editors Morton Silverman, MD, Jane E. Pirkis, PhD, Jane L. Pearson, PhD, and Joel T. Sherrill, PhD. "We are confident the articles will have a major influence on the suicide prevention research community."

The content of the supplement directly addresses research that will inform the following goals:

Proposed strategies include research into early detection of suicidal behavior, particularly among youth and adolescents, intervention, evidence-based follow-up care, and reducing stigma through the use of mass media.

Effective suicide prevention is a team effort, including both public and private partners. Contributors to the supplement stress that progress in the area of suicide prevention research will require interdisciplinary, collaborative science and that translational science and interdisciplinary research collaboration ("team science") will be critical for advancing science and ultimately identifying effective prevention strategies.

The supplement's guest editors conclude, "The papers in this supplement, like the Research Agenda itself, are intended as inspirational resources that highlight the challenges and rewards of engaging in suicide prevention research, and suggest future research directions that have the potential to advance the overall goal of reducing attempts and deaths."

Read the original post:
Prioritizing suicide research can help lead to fewer suicide attempts and deaths

Women seek anti-aging clinicians to treat menopausal symptoms, study finds

Feeling that conventional doctors did not take their suffering seriously, women instead sought out hormonal treatments for menopausal symptoms from anti-aging clinicians, according to a Case Western Reserve University study that investigated the appeal of anti-aging medicine.

Some women also feared the harmful side effects from conventional hormone replacement therapy (HRT) that had shown increased risks for cancer, heart disease and high blood pressure. Yet, they thought that the bioidentical, "natural" hormones their anti-aging doctors prescribed were safe, despite a lack of conventional scientific evidence to that fact.

Michael Flatt, a doctoral candidate in sociology at Case Western Reserve University, and Jennifer Fishman, assistant professor at McGill University, will discuss these and other findings during the presentation "'Hormones Are Where It's At': Bioidentical Hormones, Menopausal Women, and Anti-Aging Medicine" on Monday, Aug. 18, at the 109th Annual Meeting of the American Sociological Association, Aug. 16-19, in San Francisco.

The findings about the women's attitudes are part of a larger study in the Department of Bioethics at Case Western Reserve that investigated the views of scientists, doctors and patients involved with anti-aging science and medicine.

The researchers, who conducted the study with Richard Settersten Jr., professor of public health at Oregon State University, explored what it was about anti-aging medicine that appealed to women, given that the costs for care and prescribed medications were not covered by medical insurance.

Was it vanity to maintain their youthful appearance or some other motivation?

Findings from in-depth interviews with 25 women who used bioidentical hormone replacement therapy (BHRT) prescribed by an anti-aging clinician bucked the vanity-driven stereotype.

Instead, Flatt said the women told researchers they wanted to relieve their menopausal symptoms, feel energized and avoid chronic illnesses associated with aging. The women also described their motivation as wanting to return to an "optimal" state and believed that bioidentical hormones would do this.

"Hormones became the panacea reported by the women," Flatt said. "They felt that if the hormones were in order, they'd be back on track."

The anti-aging clinicians prescribed BHRT after the women took a series of tests to determine the causes of their menopausal symptoms, which purportedly included hormonal and vitamin deficiencies. They were prescribed BHRT, hormones derived from plants, like soy and yams. The hormonal therapies are unregulated by the Food and Drug Administration and made to order by compounding pharmacists.

View original post here:
Women seek anti-aging clinicians to treat menopausal symptoms, study finds

Study Finds Women Seek Anti-Aging Clinicians for Menopausal Symptoms

Contact Information

Available for logged-in reporters only

Newswise Feeling that conventional doctors did not take their suffering seriously, women instead sought out hormonal treatments for menopausal symptoms from anti-aging clinicians, according to a Case Western Reserve University study that investigated the appeal of anti-aging medicine.

Some women also feared the harmful side effects from conventional hormone replacement therapy (HRT) that had shown increased risks for cancer, heart disease and high blood pressure. Yet, they thought that the bioidentical, natural hormones their anti-aging doctors prescribed were safe, despite a lack of conventional scientific evidence to that fact.

Michael Flatt, a doctoral candidate in sociology at Case Western Reserve University, and Jennifer Fishman, assistant professor at McGill University, will discuss these and other findings during the presentation Hormones Are Where Its At: Bioidentical Hormones, Menopausal Women, and Anti-Aging Medicine on Monday, Aug. 18, at the 109th Annual Meeting of the American Sociological Association, Aug. 16-19, in San Francisco.

The findings about the womens attitudes are part of a larger study in the Department of Bioethics at Case Western Reserve that investigated the views of scientists, doctors and patients involved with anti-aging science and medicine.

The researchers, who conducted the study with Richard Settersten Jr., professor of public health at Oregon State University, explored what it was about anti-aging medicine that appealed to women, given that the costs for care and prescribed medications were not covered by medical insurance.

Was it vanity to maintain their youthful appearance or some other motivation? Findings from in-depth interviews with 25 women who used bioidentical hormone replacement therapy (BHRT) prescribed by an anti-aging clinician bucked the vanity-driven stereotype.

Instead, Flatt said the women told researchers they wanted to relieve their menopausal symptoms, feel energized and avoid chronic illnesses associated with aging. The women also described their motivation as wanting to return to an optimal state and believed that bioidentical hormones would do this.

Hormones became the panacea reported by the women, Flatt said. They felt that if the hormones were in order, theyd be back on track.

Read more here:
Study Finds Women Seek Anti-Aging Clinicians for Menopausal Symptoms

Youngest SL certified in Aesthetic Medicine by AAAM

Dr. Shanika Arsecularatne, the youngest person to be certified by the American Academy of Aesthetic Medicine (AAAM) in Sri Lanka, is very passionate about conveying the importance of Aesthetic medicine to Sri Lankans. It is an area of medical practice, which embraces multidisciplinary modalities dedicated to create a harmonious physical and psychological balance through non-invasive, minimally invasive and invasive treatment modalities, which are evidence-based.

Gaining her primary education from Holy Family Convent and Asian International School where she completed her Advanced Levels, she then went on to pursue her aspiration of becoming a Medical doctor. Fulfilling her dream, she returned to Sri Lanka to successfully pass the Sri Lankan Medical Councils licensing exam to practice in Sri Lanka.

I did my internship at the Hambantota General Hospital in Surgery, Pediatrics and was a RHO in Radiology, said Dr. Shanika reflecting on the start of her career.

While pursuing her passion of becoming a Doctor of Aesthetic Medicine, Dr. Shanika also practices in Pediatrics in a leading private Hospital in Colombo.

Having studied under many of the worlds leading specialists in Aesthetic Medicine she received the post Graduate Advanced Diploma from the American Academy of Aesthetic Medicine and is currently in the process of completing the Fellowship in Aesthetic and Anti- Aging Medicine.

Dr. Shanika is on an upward trajectory to fulfill her aspirations while providing that benefit to Sri Lankans as well.

While working in Colombo and in rural regions, I have observed various skin disorders in newborns, teenagers, and in the aging population such as, disfiguring birth marks, acne and acne scars, pigmentation, surgical or traumatic scars and skin problems associated with aging and hormonal imbalances.

Follow this link:
Youngest SL certified in Aesthetic Medicine by AAAM

One Codex in open beta for genomic data search

Aug 17, 2014 by Nancy Owano

Data, data everywhere and now as ever researchers need the best tools to make the data useful. In medicine, searching through genomic data can take some time. A startup called One Codex hopes to make difference with their genetic search platform that can process data sets quickly. A report on their work on Friday in TechCrunch noted the advantage of One Codex speed. "Currently," wrote Julian Chokkattu, "the most commonly used tool for genome searching is by using an algorithm called BLAST, Basic Local Alignment Search Tool, which compares primary biological sequence information." For Nick Greenfield, cofounder of One Codex, uploading a file to BLAST took two minutes and 30 seconds to process, compared with the One Codex system where the number was less than 1/20th of a second. The company defines One Codex as a search engine for genomic data. The TechCrunch piece describes what they offer as a service platform for genomics. Apart from using search technology," said Chokkattu, the platform also acts as an indexed, curated reference.

The company said that it can search the world's largest index of bacterial, viral, and fungal genomes. A key advantage is speed. The product can, said the company, "process next-generation datasets in minutes, not days (millions of DNA base pairs per second)."

The two founders are Nick Greenfield, former data scientist, and Nik Krumm, who has a PhD in genome sciences from the University of Washington.

Sample applications would be in clinical diagnostics, food safety and biosecurity. Right now, said TechCrunch, the company is focusing on testing their platform with hospitals and agencies. One Codex is in open beta.

Scientific interest in being able to search genomic data faster has been in evidence for some years. In 2012, MIT's news office reported on a study in Nature Biotechnology, where MIT and Harvard researchers described an algorithm "that drastically reduces the time it takes to find a particular gene sequence in a database of genomes. Moreover, the more genomes it's searching, the greater the speedup it affords, so its advantages will only compound as more data is generated."

The authors of that paper, titled "Compressive genomics," said, "In the past two decades, genomic sequencing capabilities have increased exponentially, outstripping advances in computing power. Extracting new insights from the data sets currently being generated will require not only faster computers, but also smarter algorithms." They stated that although compression schemes for BLAST and BLAT that they presented yield an increase in computational speed and in scaling, "they are only a first step."

Explore further: Team develops tool to better visualize, analyze human genomic data

More information: One Codex: onecodex.com/

2014 Phys.org

Read more from the original source:
One Codex in open beta for genomic data search